Puma Biotechnology, Inc. (PBYI) News
Track canonical SquawkNews coverage tagged to PBYI, Puma Biotechnology, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
PBYI: Revenue and clinical momentum accelerate, with biomarker-driven trials advancing in 2026
NERLYNX continues to drive revenue growth, with raised guidance for 2026 and strong U.S. and international sales. Alisertib's phase II trials in breast and lung cancer show promising efficacy, especially in biomarker-def
EARNINGS | Sep 14, 2026, 08:39 PM UTC
H
PBYI: Strong revenue growth and promising clinical progress with biomarker-driven cancer therapies
NERLYNX continues to show strong revenue growth and expanded guidance, while alisertib advances in phase II trials for breast and lung cancer with promising biomarker-driven results. Additional interim data and a focus o
EARNINGS | Sep 14, 2026, 08:06 PM UTC
L
Puma Biotechnology to present at H.C. Wainwright 28th Annual Global Investment Conference
Puma Biotechnology said Alan H. Auerbach will provide an overview of Puma at 3:30 p.m. ET on Monday, September 14, at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 09, 2026, 08:11 PM UTC
L
Puma Biotechnology board panel approves inducement RSU awards
Puma Biotechnology’s Compensation Committee approved inducement restricted stock unit awards covering 33,550 shares to five new non-executive employees, under Nasdaq Listing Rule 5635(c)(4), dated Sept. 1, 2026.
EQUITY | Sep 03, 2026, 09:00 PM UTC
L
Puma Biotechnology Raises FY2026 Sales Guidance from $222.000M-$229.000M to $224.000M-$231.000M vs $222.000M Est
Puma Biotechnology (NASDAQ: PBYI ) raises FY2026 sales outlook from $222.000 million-$229.000 million to $224.000 million-$231.000 million vs $222.000 million estimate.
EARNINGS | Aug 06, 2026, 08:40 PM UTC